Cutaneous Melanoma Risk and Menopausal Hormone Therapy

Source: Dermatology Advisor, August 2021

Estrogen therapy and estrogen-progestin therapy were not associated with an increased risk for cutaneous melanoma, according to results from a nationwide cohort study presented in a research letter published in the British Journal of Dermatology.

READ THE ORIGINAL FULL ARTICLE

 

Menu